Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2005
06/09/2005CA2545473A1 Macromolecular drug complexes having improved stability and therapeutic use of the same
06/09/2005CA2545262A1 Quinazoline derivatives
06/09/2005CA2545192A1 Method of treatment of atherosclerosis
06/09/2005CA2545023A1 Novel salicylic anilides
06/09/2005CA2544857A1 Vitamin d receptor modulators
06/09/2005CA2544522A1 Vitamin d receptor modulators
06/09/2005CA2544519A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
06/09/2005CA2544502A1 Vitamin d analogs for obesity prevention and treatment
06/09/2005CA2544480A1 Novel 8-(piperazine-1-yl)- and 8-([1,4]diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug
06/09/2005CA2544404A1 Novel nimesulide compositions
06/09/2005CA2543858A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
06/09/2005CA2538478A1 A pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
06/08/2005EP1538684A1 Process for doping organic semiconductors with derivatives of diiminoquinones
06/08/2005EP1538208A2 Mutants of streptococcal toxin A and methods of use
06/08/2005EP1538200A1 Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide
06/08/2005EP1538162A2 Compositions for altering mucus secretion
06/08/2005EP1538160A1 Substituted Isoquinolin-3-carboxyamides, their preparation and medical use
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1537896A1 Compound mixtures based on sulphur containing amino acids, antioxidants, phospholipids and vitamins for the preparation of a medicament for treating L-diabetes and/or associated diseases.
06/08/2005EP1537880A1 Sustained release preparation
06/08/2005EP1537879A1 Preventive and/or therapeutic drugs for asthma
06/08/2005EP1537878A1 Immunopotentiating compositions
06/08/2005EP1537877A2 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
06/08/2005EP1537871A1 Enoxaparin for the treatment of cancer
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537869A2 Radiosensibilizer and preparation thereof
06/08/2005EP1537868A1 Antifungal medicinal compositions
06/08/2005EP1537867A1 Method of photodynamic diagnosis for vascular diseases
06/08/2005EP1537866A1 Drug for kidney failure containing oxaluric acid derivative
06/08/2005EP1537865A1 Use of sulfur containing compounds and proteolytic enzymes for the prevention and therapy of the UDP-Glucuronosyltransferase 1 deficient Type II Diabetes mellitus
06/08/2005EP1537864A1 Use of amino acids and sulphur-containing compounds for the prevention and therapy of the UDP Glucuronosyltransferase 1 deficient Type II Diabetes mellitus
06/08/2005EP1537863A1 Preventive therapeutic composition for muscular fatigue, pulled muscle and disease attributed thereto
06/08/2005EP1537862A1 Novel use of peptide compounds for treating central neuropathic pain
06/08/2005EP1537861A2 Use of aminothiol compounds for the treatment xerostomia caused by therapeutic agents or radiation
06/08/2005EP1537859A2 Azithromycin dosage forms with reduced side effects
06/08/2005EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof
06/08/2005EP1537855A1 Cosmetic composition comprising licochalcone A or an extract of Glycyrrhiza inflatae comprising licochalcone A and an organic thickener
06/08/2005EP1537789A1 Composition for oral or cosmetic application
06/08/2005EP1537417A2 Method of diagnosing colon and gastric cancers
06/08/2005EP1537243A1 Method of diagnosing ovarian endometriosis
06/08/2005EP1537226A1 Method for reproducing pleuromutilins
06/08/2005EP1537212A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases
06/08/2005EP1537210A1 Decoy-oligonucleotide-inhbition of cd40-expression
06/08/2005EP1537208A1 Non-sequence complementary antiviral oligonucleotides
06/08/2005EP1537195A1 Desinfecting composition
06/08/2005EP1537163A2 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
06/08/2005EP1537145A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins
06/08/2005EP1537140A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
06/08/2005EP1537135A2 Adenosine a3 receptor agonists
06/08/2005EP1537133A2 Partial and full agonists of a1 adenosine receptors
06/08/2005EP1537132A1 Salt of morphine-6-glucuronide
06/08/2005EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof
06/08/2005EP1537124A1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
06/08/2005EP1537123A1 Compounds
06/08/2005EP1537122A1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
06/08/2005EP1537117A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents
06/08/2005EP1537116A1 Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
06/08/2005EP1537115A1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
06/08/2005EP1537113A1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
06/08/2005EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity
06/08/2005EP1537110A2 Triazospiro compounds having nociceptin receptor affinity
06/08/2005EP1537109A1 Novel benzonaphthyridines
06/08/2005EP1537106A1 Dihydropyrazolopyridine compounds
06/08/2005EP1537104A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
06/08/2005EP1537102A1 Inhibition of phsphoinostide 3-dinase beta
06/08/2005EP1537100A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537085A1 Oxytocin inhibitors
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537079A2 PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
06/08/2005EP1537078A1 Indoles having anti-diabetic activity
06/08/2005EP1537076A1 Novel vinyl carboxylic acid derivatives and their therapeutical use
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
06/08/2005EP1537072A1 Substituted aminoethers for the treatment of alzheimer s disease
06/08/2005EP1537070A1 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof
06/08/2005EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
06/08/2005EP1537068A1 Materials and methods for treating hypercholesterolemia
06/08/2005EP1537067A2 Resolvins: biotemplates for therapeutic interventions
06/08/2005EP1537065A1 Analogues of vitamin d
06/08/2005EP1536863A1 Use of cyclooxygenase-2 selective inhibitors and thrombolytic agents for the treatment or prevention of a vaso-occlusive event
06/08/2005EP1536850A1 Medical device having hydration inhibitor
06/08/2005EP1536845A1 Wound dressing materials comprising complexes of anionic polysaccharides with silver
06/08/2005EP1536840A2 Formulation for inwardly transferring nucleic acids into eucaryotic cells
06/08/2005EP1536839A2 Method for treating diseases with omega interferon
06/08/2005EP1536837A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
06/08/2005EP1536836A2 Topical emulsion- gel composition comprising diclofenac sodium
06/08/2005EP1536835A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
06/08/2005EP1536820A2 Cancer therapy using whole glucan particles and antibodies
06/08/2005EP1536819A2 Use of rom production and release inhibitors to treat and prevent intraocular damage
06/08/2005EP1536813A2 Compositions and methods comprising protein activated receptor antagonists
06/08/2005EP1536812A2 Methods for modulating activity of the fxr nuclear receptor
06/08/2005EP1536810A2 Extraction of pharmaceutically active cannabinoids from plant materials
06/08/2005EP1536806A1 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
06/08/2005EP1536805A1 Nutricional compositions comprising a non-glucose carbohydrate or pectin and soluble fiber
06/08/2005EP1536804A2 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
06/08/2005EP1536803A2 Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
1 ... 4662 4663 4664 4665 4666 4667 4668 4669 4670 4671 4672 4673 4674 4675 4676 4677 4678 4679 4680 4681 4682 ... 7860